Resultados de la búsqueda 641-650 of 11047 for 搜索引擎yeardx咨询邮箱：lgooxc@hotmail.com

  1. Ensayos clínicos - Neurología

    A total of 8,000 patients presenting to CPSs with acute-onset AIS, ICH or aSAH and no history of dementia will be enrolled within 6 weeks of stroke onset. All ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This study aims to identify candidate High Grade Serous Cancer (HGSC) early detection and chemotherapy treatment response biomarkers. For the purpose of this ...

  3. Cirugía - Ensayos clínicos

    The purpose of this study is to combine MRI images with histologic and genetic analysis of cancer (from blood and tissue samples) to improve the overall ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The primary objective of the trial is to evaluate if L19TNF in combination with doxorubicin (Arm 2) given for unresectable or metastatic soft tissue sarcoma ...

  5. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen ...

  6. Departamento de Oftalmología de Mayo Clinic - Ensayos clínicos

    The purpose of this study is to use Ultrasound surface wave elastography to measure and compare the tissue thickness and elasticity in normal eyes and eyes with ...

  7. Oncología (médica) - Ensayos clínicos

    After enrollment, patients will receive one cycle of Induction chemotherapy. Subsequent therapy will be based upon MIBG avidity and ALK status. Patients with ...

  8. Centro Pediátrico de Mayo Clinic

    The purpose of this study is to confirm detection of the H3K27M mutation in patient biofluids (CSF, blood, urine, saliva) and uncover the molecular histone ...

  9. Cáncer de mama - Médicos y departamentos - Mayo Clinic

    Obtén información acerca de este cáncer frecuente, incluso sobre la prevención, los síntomas, el diagnóstico y el tratamiento.

  10. Oncología (médica) - Ensayos clínicos

    The trial will be conducted in 2 parts: an initial Dose Escalation Phase (Part A) of CA-4948 in patients with Relapsed or Refractory Non-Hodgkin Lymphoma, (RR ...